Altfest L J & Co Inc reports 0.83% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Altfest L J & Co Inc
Latest Disclosed Ownership	27,862 shares
Latest Disclosed Value	$ 1,689,839

On April 28, 2026 - Altfest L J & Co Inc filed a 13F-HR form disclosing ownership of 27,862 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,460,526 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 28,095 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.83% during the quarter. The current value of the position is $1,321,495 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-28	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	27,862	-233	-0.83	1,690	11.49	0.1797
2026-01-23	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	28,095	430	1.55	1,515	21.49	0.1659
2025-10-21	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	27,665	-6,195	-18.30	1,248	-20.42	0.1392
2025-08-08	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	33,860	-4,053	-10.69	1,567	-32.22	0.1848
2025-05-09	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	37,913	1,745	4.82	2,312	13.06	0.2900
2025-02-07	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	36,168	9,222	34.22	2,046	204,400.00	0.2609
2024-11-05	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,946	580	2.20	1	0.00	0.1856
2024-08-07	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,366	-83	-0.31	1	0.00	0.1496
2024-04-22	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,449	-232	-0.87	1	0.00	0.2031
2024-01-18	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,681	-3,468	-11.50	1	0.00	0.1985
2023-10-26	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	30,149	-2,712	-8.25	2	-50.00	0.2760
2023-08-09	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	32,861	2,406	7.90	2	0.00	0.3157
2023-04-20	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	30,455	-164	-0.54	2	0.00	0.3307
2023-02-02	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	30,619	-703	-2.24	2	-99.91	0.3650
2022-11-15	2022-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	31,322	-46	-0.15	2,227	-7.78	0.4176
2022-08-04	2022-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	31,368	-270	-0.85	2,415	4.50	0.4339
2022-05-02	2022-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	31,638	-7,921	-20.02	2,311	-6.32	0.4122
2022-01-24	2021-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	39,559	8,921	29.12	2,467	36.07	0.4706
2021-10-12	2021-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	30,638	-3,329	-9.80	1,813	-20.13	0.3799
2021-07-28	2021-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	33,967	-381	-1.11	2,270	4.70	0.4893
2021-05-07	2021-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	34,348	302	0.89	2,168	2.65	0.5124
2021-01-21	2020-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	34,046	3,345	10.90	2,112	14.10	0.5175
2020-10-29	2020-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	30,701	-1,383	-4.31	1,851	-1.91	0.4921
2020-07-21	2020-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	32,084	-4,723	-12.83	1,887	-8.04	0.5431
2020-04-13	2020-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	36,807	-315	-0.85	2,052	-13.89	0.6426
2020-01-06	2019-12-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	37,122	153	0.41	2,383	27.09	0.6005
2019-10-10	2019-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	36,969	-5,683	-13.32	1,875	-3.05	0.4835
2019-07-15	2019-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	42,652	-1,343	-3.05	1,934	-7.86	0.5147
2019-06-10	2019-03-31	13F/A-2	BRISTOL MYERS SQUIBB	COM	110122108	43,995	-1,230	-2.72	2,099	-10.72	0.5110
2019-05-24	2019-03-31	13F/A-1	BRISTOL MYERS SQUIBB	COM	110122108	45,225	1,230		2,351		0.6327
2019-04-05	2019-03-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	18,621	-26,604		2,403
2019-01-15	2018-12-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	45,225	-2,564	-5.37	2,351	-20.76	0.6566
2018-10-10	2018-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	47,789	-161	-0.34	2,967	11.79	0.8636
2018-08-07	2018-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	47,950	-11,724	-19.65	2,654	-29.68	0.9883
2018-05-09	2018-03-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	59,674	-1,126	-1.85	3,774	1.29	1.6281
2018-02-12	2017-12-31	13F	Bristol Myers	COM	110122108	60,800	3,237	5.62	3,726	1.55	1.4148
2017-10-23	2017-09-30	13F	Bristol Myers	COM	110122108	57,563	653	1.15	3,669	15.70	1.7835
2017-07-21	2017-06-30	13F	Bristol Myers	COM	110122108	56,910	6,772	13.51	3,171	16.32	1.9143
2017-05-03	2017-03-31	13F	Bristol Myers	COM	110122108	50,138	4,254	9.27	2,726	1.68	1.0827
2017-01-09	2016-12-31	13F	Bristol Myers	COM	110122108	45,884	-574	-1.24	2,681	7.03	1.3393
2016-11-16	2016-09-30	13F	Bristol Myers	COM	110122108	46,458	349	0.76	2,505	-26.13	1.6685
2016-11-16	2016-06-30	13F	Bristol Myers	COM	110122108	46,109	-501	-1.07	3,391	13.91	2.3623
2016-05-13	2016-03-31	13F	Bristol Myers	COM	110122108	46,610	259	0.56	2,977	-6.62	3.0644
2016-02-19	2015-12-31	13F	Bristol Myers	COM	110122108	46,351	-1,345	-2.82	3,188	12.89	3.1201
2015-10-14	2015-09-30	13F	Bristol Myers	COM	110122108	47,696	-1,085	-2.22	2,824	-13.00	2.7889
2015-07-17	2015-06-30	13F	Bristol Myers	COM	110122108	48,781	-637	-1.29	3,246	1.85	2.9762
2015-04-20	2015-03-31	13F	Bristol Myers	COM	110122108	49,418	-426	-0.85	3,187	8.33	2.9665
2015-02-23	2014-12-31	13F/A-1	Bristol Myers	COM	110122108	49,844	-599	-1.19	2,942	14.70	2.4058
2015-02-11	2014-12-31	13F	Bristol Myers	COM	110122108	49,844			2,942
2014-11-14	2014-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	50,443	-2,586	-4.88	2,565	0.75	2.5211
2014-08-14	2014-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	53,029	1,738	3.39	2,546	1.64	2.5078
2014-05-13	2014-03-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	51,291	-370	-0.72	2,505	-8.78	2.3264
2014-02-14	2013-12-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	51,661	51,661		2,746		2.3374

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.